![Myasthenia gravis — autoantibody characteristics and their implications for therapy | Nature Reviews Neurology Myasthenia gravis — autoantibody characteristics and their implications for therapy | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneurol.2016.44/MediaObjects/41582_2016_Article_BFnrneurol201644_Fig1_HTML.jpg)
Myasthenia gravis — autoantibody characteristics and their implications for therapy | Nature Reviews Neurology
![Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients | Journal of Neuroinflammation | Full Text Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-022-02448-4/MediaObjects/12974_2022_2448_Figa_HTML.png)
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients | Journal of Neuroinflammation | Full Text
![Immune checkpoints could be key to treating autoimmune disease myasthenia gravis – Kanazawa University Immune checkpoints could be key to treating autoimmune disease myasthenia gravis – Kanazawa University](https://www.kanazawa-u.ac.jp/wp/wp-content/uploads/2018/11/181128_02Figure-1.jpg)
Immune checkpoints could be key to treating autoimmune disease myasthenia gravis – Kanazawa University
![Frontiers | Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology Frontiers | Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology](https://www.frontiersin.org/files/MyHome%20Article%20Library/526494/526494_Thumb_400.jpg)
Frontiers | Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
![Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology](https://www.thelancet.com/cms/attachment/5a1af1a5-7f6e-47d1-8b01-179f5e88c563/gr1_lrg.jpg)
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology
![Neurology International | Free Full-Text | The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review Neurology International | Free Full-Text | The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review](https://pub.mdpi-res.com/neurolint/neurolint-15-00026/article_deploy/html/images/neurolint-15-00026-g001.png?1678438810)